BioCryst
Trade BioCryst 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
BCRX Key Statistics
Stock Snapshot
With a market cap of 1.65B, BioCryst(BCRX) trades at $8.00. The stock has a price-to-earnings ratio of -165.54.
On 2025-12-04, BioCryst(BCRX) stock moved within a range of $7.79 to $8.17. With shares now at $8.00, the stock is trading +2.7% above its intraday low and -2.1% below the session's peak.
Trading volume for BioCryst(BCRX) stock has reached 6.72M, versus its average volume of 4.4M.
Over the past 52 weeks, BioCryst(BCRX) stock has traded between a high of $11.31 and a low of $6.00.
Over the past 52 weeks, BioCryst(BCRX) stock has traded between a high of $11.31 and a low of $6.00.
BCRX News
BioCryst (BCRX) Pharmaceuticals announced that the compensation committee of BioCryst’s board of directors granted four newly-hired employees stock options to p...
BioCryst Pharmaceuticals recently announced new one-year data from its APeX-P trial, highlighting that ORLADEYO (berotralstat) treatment led to early and sustai...
